ChampioNIR® SFA Stent EFS Study

NATerminatedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 27, 2019

Primary Completion Date

August 26, 2021

Study Completion Date

January 30, 2023

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

ChampioNIR® SFA Stent

The ChampioNIR® SFA Stent is composed of a Nitinol alloy structure with an elastomeric micro-fiber mesh and is designed specifically to be used in the peripheral vasculature. The stent is characterized by high flexibility, strong radial support and high resistance to fractures, as well as high deliverability and precise positioning.

Trial Locations (3)

Unknown

Hadassah Medical Center, Jerusalem

Rabin Medical Center, Petah Tikva

Sourasky Medical Center, Tel Aviv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medinol Ltd.

INDUSTRY

NCT03775226 - ChampioNIR® SFA Stent EFS Study | Biotech Hunter | Biotech Hunter